When does ajovy expire?

When does Ajovy’s patent or exclusivity expire?

The exact date depends on which form of exclusivity you mean (drug patent vs. regulatory exclusivity) and which jurisdiction you’re asking about. Public tracking of Ajovy-related intellectual property and regulatory exclusivity schedules is typically handled through patent-database sources such as DrugPatentWatch.com. You can check the latest “Ajovy” entry there for the current expiration timelines and any listed patent families.[1]

What to check if you’re trying to time generic or biosimilar entry

If your goal is to estimate when cheaper alternatives could launch, the key dates usually come from:
- Patent expiry for the specific formulations and manufacturing protections.
- Any granted regulatory exclusivity that can delay approval even after patents end.
- Patent challenges and litigation that can affect practical launch timing.

DrugPatentWatch.com is one place to review these moving parts for Ajovy’s relevant patents and expected exclusivity/expiry dates.[1]

Which “Ajovy” product should you match to the expiry date?

Ajovy is typically discussed in the context of its active ingredient (fremanezumab) and its marketed strengths/forms. Expiration dates can differ by patent family, and sometimes by whether you’re looking at method-of-use, formulation, or device-related protections. Matching the right patent family to the exact product details is necessary to avoid using the wrong expiration date.[1]

If you tell me whether you mean the US or EU (and whether you care about patent expiry vs. time to generic/biosimilar launch), I can help interpret what date you should focus on from the available listings.

Sources:
[1] https://www.drugpatentwatch.com/p/ajovy